2Phillips M,Allen C,Gerson P,et al.Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis[J].Pediatric Blood & Cancer,2009,52(1):97-101.
3Zur SU,Beutel K,Kolberg S. Mutation spectrum in children with primmy hemophagocytic lymphohistiocytosis:molecular and functional analyses of PRFI,UNCi3D,STXll and RAB27A[J].Hum Mutst,2006,(01):62-68.
4Nereid C,Basset F. An hypothesis of Langerhans cell histiocytesis:the failure of the immune system to switch from all innate to an adaptive mode[J].{H}PEDIATRIC BLOOD & CANCER,2004,(05):398-400.
5Senechal B,Elain G,Jeziorski E. Expansion of Regulatory T Ceils in Patients with Langerhans Cell Histiocytosis[J].{H}PLOS MEDICINE,2007,(08):e253.
6Allen CE,Li L,Peters TL. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells[J].{H}Immunology,2010,(08):4557-4567.
7Minkov M. Multisystem Langerhans cell histioeytosis in children:current treatment and future directions[J].{H}Paediatric Drugs,2011,(02):75-86.
8Bernard F,Thomas C,Bertrand Y. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction[J].{H}EUROPEAN JOURNAL OF CANCER,2005,(17):2682-2689.
9Lai CC,Hnang WC,Cheng SN. Successful treatment of refractory Langerhans cell histiocytosis by allogeneic peripheral blood stem cell transplantation[J].{H}Pediatric Transplantation,2008,(01):99-104.
10Steiner M,Matthes-Martin S,Attarbaschi A. Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis[J].{H}HAEMATOLOGICA,2007,(01):e3-e4.
